本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

13.15
+0.41003.22%
盘后13.400.2500+1.90%17:04 EDT
成交量:121.16万
成交额:1,601.80万
市值:19.10亿
市盈率:-5.12
高:13.66
开:12.59
低:12.31
收:12.74
数据加载中...
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]